AIM ImmunoTech Inc. — Director's Dealing 2012

Jun 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2012-06-05

Reporting Person: Dickey Robert IV (Senior Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-05	Options to Buy Common Stock	$0.29	J	50000	Acquired	2022-06-05	Common Stock (50000)	Direct

Footnotes

F1: Board of Directors granted options to purchase shares of HEB common stock.